Profile picture

Doctor Anna Camps-Vilaro

Hospital del Mar Medical Research Institute (IMIM), Barcelona (Spain)
Membership: EAPC Member
Follow
Biography
Anna Camps-Vilaro holds a degree in Pharmacy (University of Barcelona), a Master's degree in Study Coordination and Clinical Trials, and a PhD in Medicine and Biomedical Sciences. Anna's research primarily focuses on cardiovascular epidemiology, specifically analyzing trends in ischemic heart disease, studying biomarkers of atherosclerosis, and improving risk assessment functions in both the general population and specific risk situations such as HIV and SARS-CoV-2 infections. She has published over ten scientific articles in high-impact journals, presented her work at national and international congresses, participated in nine national projects (one as co-principal investigator), co-supervised a final degree project, and supervised several student internships. Furthermore, Anna is a co-author of a patent and has been recognized with the Young Investigator Award at the 2022 European Society of Preventive Cardiology congress.
Logo ESC

Contributor content

PRS predict baseline risk but not statin or ACEi effects
Presentation
PRS predict baseline risk but not statin or ACEi effects
Age-standardized comparison of cardiovascular events and all-cause mortality in people living with HIV and in general population
Presentation
Age-standardized comparison of cardiovascular events and all-cause mortality in people living with HIV and in general population
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study.
Presentation
Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study.
Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study.
Presentation
Genetic risk score for risk stratification of patients positive for SARS-CoV-2 virus. The CARGENCORS study.
Relationship of 5-year changes in inflammatory, metabolic and oxidative biomarkers with cardiovascular diseases incidence at 10-years.
Presentation
Relationship of 5-year changes in inflammatory, metabolic and oxidative biomarkers with cardiovascular diseases incidence at 10-years.
Validity and trends of myocardial infarction incidence and case-fatality estimated from linked administrative databases
Presentation
Validity and trends of myocardial infarction incidence and case-fatality estimated from linked administrative databases
Standardized comparison of cardiovascular risk factors prevalence in Spanish women and men living with HIV and in the general population
Presentation
Standardized comparison of cardiovascular risk factors prevalence in Spanish women and men living with HIV and in the general population

ESC 365 is supported by